Our expanding infectious diseases pipeline is comprised of transformational medical innovations. These therapies and vaccines are redefining viral infections like human immunodeficiency virus (HIV), hepatitis C (HCV) and, in the case of our pentavalent vaccine, evaluating the prevention of serious childhood infections. In all of these areas, we are both making and developing solutions that aim to make a crucial contribution to global public health.
You can view the full list of our approved products in Infectious Diseases & Vaccines here.